9th Jan 2006 07:30
SDL PLC09 January 2006 GSK Partners with SDL to Speed Product Submissions Selects SDL GIM solution for new XML product information standard Maidenhead, UK - 9 January 2006 - SDL International, a leader in the emergingmarket for global information management (GIM) solutions, announced today thatGlaxoSmithKline (GSK) has awarded SDL a contract worth over £300,000 fortechnology and consulting services to implement simultaneous multilingualproduct submissions to the European Medicines Agency (EMEA). GSK expects to see significant business advantages by reducing the timenecessary to pass the EMEA regulatory process through the deployment of the SDLGIM solution. A key decision factor was SDL's ability to support and enhance theprocess of creating content compliant with EMEA's XML-based product information(PIM) standard and adapting the XML content to the European Union's 20languages. The SDL GIM solution, including SDL TeamWorks, will be used to optimize andautomate the translation processes across the 20 European Union languages. GSKwill leverage SDL's centralized translation memory to maximize reuse ofpreviously translated content, with SDL TeamWorks' collaborative workflowcapabilities providing efficient translation change management during therevision cycles with the regulator. SDL enterprise consulting services willintegrate Arbortext technologies for authoring and Documentum CMS for the XMLproduct information into the unified GIM solution. "GSK is leading the industry in adoption of the new PIM standard," commentedStephen R Hasler, Vice President Operations and Systems, Europe andInternational Regulatory Affairs at GlaxoSmithKline. "SDL has demonstratedthorough understanding of the technical and business issues involved and weanticipate significant time-to-market advantages once this new solution isimplemented." "SDL's expertise in multilingual XML content management and domain knowledge ofthe life sciences industry will enable us to rapidly implement the newintegrated GIM solution for GSK," said Phil Gilbert, Life Sciences IndustryDirector at SDL. "Our management of authoring, translation and publishingprocesses will guarantee quality standards, speed up product submissions andimprove the profitability of new products." About GlaxoSmithKline GSK, one of the world's leading research-based pharmaceutical and healthcarecompanies, is committed to improving the quality of human life by enablingpeople to do more, feel better and live longer. For further information, visitwww.gsk.com. About SDL International SDL International (London Stock Exchange: 'SDL') is a leader in the emergingmarket for global information management (GIM) solutions that empowerorganizations to accelerate the delivery of high-quality multilingual content toglobal markets. Its enterprise software and services integrate with existingbusiness systems to manage global information from authoring to publication andthroughout the distributed localization supply chain. Global industry leaders such as Audi, Bayer, Best Western, Bosch, Canon,Deutsche Bank, Kodak, Microsoft, Morgan Stanley, Reuters, and SAP rely on SDL toprovide enterprise software or full outsourcing for their GIM processes. SDL hasimplemented more than 100 enterprise GIM solutions, has over 100,000 softwarelicenses deployed across the GIM ecosystem and its global servicesinfrastructure spans more than 50 offices in 30 countries. For more information, visit www.sdl.com. For information on SDL, please contact: Fiona Ribeiro Tel: +44 (0)1628 410120 Email: [email protected] All trademarks are the property of their respective owners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SDL.L